Measuring TEER in X-ray-Irradiated Epithelial Cells Co-cultured With PBMCs

Executive Industry Relevance

Quantitative TEER measurement in X-ray-irradiated epithelial cell and PBMC co-cultures enables precise assessment of barrier integrity under immune and radiation stress. This approach supports mechanistic de-risking of epithelial permeability changes, informing early-stage target validation and predictive model development. The method is positioned for portfolio teams seeking robust, reproducible readouts of barrier function in disease-relevant systems.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables interrogation of epithelial barrier disruption mechanisms following radiation and immune cell interaction.
• Supports functional target validation by quantifying tight junction integrity in response to defined perturbations.
• Facilitates predictive confidence in selecting targets or pathways involved in barrier regulation.

Screening & Assay Development

• Provides a standardized, quantitative assay for assessing monolayer permeability in co-culture systems.
• Delivers reproducible TEER outputs suitable for assay optimization and downstream screening workflows.
• Enables reliable evaluation of compound or biologic effects on epithelial barrier function.

Translational & Preclinical Research

• Models disease-relevant epithelial-immune interactions for translational biomarker alignment.
• Supports continuity from in vitro discovery to preclinical validation of barrier-modulating interventions.
• Informs risk-adjusted advancement decisions by quantifying functional barrier outcomes.

Pipeline & Workflow Integration

This TEER-based method integrates into the discovery-to-preclinical continuum, bridging mechanistic studies and translational model development.

• Discovery Biology: Quantifies barrier disruption to clarify pathway involvement and de-risk mechanistic hypotheses.
• Screening: Provides assay-ready, reproducible TEER measurements for compound evaluation.
• Analytics: Generates quantitative resistance data enabling condition comparison and statistical analysis.
• Translational Research: Aligns in vitro barrier outcomes with preclinical disease models when supported by system relevance.
• Enterprise Reuse: Offers a reusable platform for diverse epithelial-immune interaction studies across programs.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in barrier function studies.
• Operational Value: Standardizes permeability assessment and supports scalable, reproducible workflows.
• Strategic Value: Improves go/no-go decisions and reduces late-stage biological risk by providing robust functional readouts.
• Portfolio Impact: Enables risk-adjusted prioritization of targets and pathways affecting epithelial integrity.

Implementation Considerations

• Requires expertise in epithelial cell culture and co-culture system setup.
• Needs access to TEER measurement instrumentation and analytical infrastructure.
• Demands cross-team standardization of assay conditions and data interpretation.
• May require adaptation for different epithelial or immune cell types based on project needs.
• Practical limitations include sensitivity to culture conditions and time-dependent measurement windows.

Biopharma FAQs